Prosecution Disclaimer Alive and Well, Especially in Closed Claim
By EsqSocial Corporation 17/04/25
The US Court of Appeals for the Federal Circuit affirmed a district court’s noninfringement determination, finding that the presence of a disclaimed compound in the accused product precluded infringement. Azurity Pharm., Inc. v. Alkem Lab’ys Ltd., Case No. 23-1977 (Fed. Cir. Apr. 8, 2025) (Moore, Chen, Murphy, JJ.)...
By: McDermott Will & Emery